OMIXON
HQ - Budapest
Summary
Omixon is a global transplantation diagnostic company focused on the development and commercialization of Next Generation Sequencing technologies.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 19 M
Avg. Deal Size£ 19 M
Senior Management
Attila Berces
Founder and CEO
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite